In fact, a previous study showed that linc00513 was a novel positive regulator of the type I interferon pathway by promoting the phosphorylation of the transcription factors STAT1 and STAT2 in SLE patients (Xue et al., 2018). This evidence concerns the gene LINC00513 and systemic lupus erythematosus.